日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical Impact and Cost-Effectiveness of Updated 2023/24 COVID-19 mRNA Vaccination in High-Risk Populations in the United States

美国高危人群中更新的2023/24年COVID-19 mRNA疫苗的临床影响和成本效益

Joshi, Keya; Dronova, Mariia; Paterak, Ewelina; Nguyen, Van H; Kopel, Hagit; Mansi, James; Van de Velde, Nicolas; Beck, Ekkehard

The impact of amortization of gene therapies funding on the results and conclusions of CEMs and BIMs

基因疗法资金摊销对CEM和BIM结果和结论的影响

Polek, Hubert; Janik, Justyna; Paterak, Ewelina; Dabbous, Monique; Pochopień, Michał; Toumi, Mondher

Gene Therapy Evidence Generation and Economic Analysis: Pragmatic Considerations to Facilitate Fit-for-Purpose Health Technology Assessment

基因治疗证据生成与经济分析:促进适用性卫生技术评估的务实考量

Qiu, Tingting; Pochopien, Michal; Liang, Shuyao; Saal, Gauri; Paterak, Ewelina; Janik, Justyna; Toumi, Mondher

An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models

基因疗法卫生技术评估概述,重点关注成本效益模型

Pochopień, Michał; Paterak, Ewelina; Clay, Emilie; Janik, Justyna; Aballea, Samuel; Biernikiewicz, Małgorzata; Toumi, Mondher